ExeVir Bio

ExeVir Bio

Verified
Develops single-domain antibody-based therapies that help patients ward off viral infections

Launch date
Employees
Ownership
Firm valuation
$135m (Dealroom.co estimates Mar 2021.)
Ghent East Flanders (HQ)
  • Edit

Recent News about ExeVir Bio

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.